BAM
Bosun Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $727K | Sell |
3,917
-331
| -8% | -$61.4K | 0.22% | 105 |
|
|
2025
Q1 | $890K | Buy |
4,248
+20
| +0.5% | +$4.19K | 0.38% | 59 |
|
|
2024
Q4 | $751K | Sell |
4,228
-202
| -5% | -$35.9K | 0.33% | 84 |
|
|
2024
Q3 | $875K | Buy |
4,430
+199
| +5% | +$39.3K | 0.42% | 66 |
|
|
2024
Q2 | $726K | Buy |
4,231
+403
| +11% | +$69.1K | 0.43% | 59 |
|
|
2024
Q1 | $697K | Sell |
3,828
-4,683
| -55% | -$853K | 0.4% | 78 |
|
|
2023
Q4 | $1.32M | Sell |
8,511
-198
| -2% | -$30.7K | 1.31% | 16 |
|
|
2023
Q3 | $1.3M | Sell |
8,709
-298
| -3% | -$44.4K | 1.41% | 13 |
|
|
2023
Q2 | $1.21M | Buy |
9,007
+700
| +8% | +$94.3K | 1.19% | 15 |
|
|
2023
Q1 | $1.32M | Buy |
8,307
+3,300
| +66% | +$526K | 1.51% | 9 |
|
|
2022
Q4 | $809K | Sell |
5,007
-100
| -2% | -$16.2K | 1.15% | 15 |
|
|
2022
Q3 | $685K | Buy |
5,107
+1,500
| +42% | +$201K | 1.06% | 17 |
|
|
2022
Q2 | $552K | Sell |
3,607
-5
| -0.1% | -$765 | 0.76% | 29 |
|
|
2022
Q1 | $585K | Hold |
3,612
| – | – | 0.61% | 31 |
|
|
2021
Q4 | $489K | Buy |
+3,612
| New | +$489K | 0.44% | 34 |
|